Hematology Clinical Trials Program

The Hematology Clinical Trials Program at Children's Hospital allows children with blood disorders and their families to participate in national and international research studies. If your child is eligible for a study, you can help improve our understanding of hematologic disorders. This can determine the best treatments for your child and other patients.

Our clinical trials include studies that investigate the cause, development and effects of hematologic disorders. We also pursue studies to improve population health and to discover new treatment options for our patients.

Conditions We Treat

  • checkmark icon
  • checkmark icon
    Sickle-cell anemia
  • checkmark icon
    Thalassemia
  • checkmark icon
    Hereditary spherocytosis and other red cell disorders
  • checkmark icon
    G6PD
  • checkmark icon
    Immune thrombocytopenia (ITP)
  • checkmark icon
    Congenital anemias
  • checkmark icon
    Iron deficiency anemia

Meet Your Care Team

Alexandra J. Borst
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.9

Alexandra J. BorstMD

    Pediatric Hematology/Oncology
Michael R. Debaun

Michael R. DebaunMD, MPH

    Pediatric Hematology/Oncology
Heather L. McDaniel
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.8

Heather L. McDanielMD, MSCI

    Pediatric Hematology/Oncology
Jennifer A. Murdock

Jennifer A. MurdockMD

    Blood Banking and Transfusion Medicine
Emmanuel J. Volanakis

Emmanuel J. VolanakisMD

    Pediatric Hematology/Oncology
Allison P. Wheeler

Allison P. WheelerMD, MSCI

    Hematology, Pediatric Hematology/Oncology

Why Choose Care at the Vanderbilt Hematology Clinical Trials Program

  • Recognized care

    Vanderbilt offers a nationally recognized, federally funded Hemophilia Treatment Center (HTC) that can aid in clinical support for our patients throughout research trials. Our research team, including research nurses, data specialists and other support staff, chooses studies that will not only benefit the HTC community, but will also provide up-to-date and novel treatment options for patients who choose to participate.

  • Comprehensive care

    Our comprehensive program for children with clotting disorders coordinates care with our other subspecialty care teams. We aim to improve anticoagulation safety and options for your child.

  • Sickle Cell Center of Excellence

    The Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease is a federally funded program and a national leader in sickle cell treatment and research. We participate in both national and international studies aimed to improve our understanding of Sickle Cell Disease and improve treatment options for your child.

  • Increasing options

    As our program grows, we will continue providing more options to improve our understanding of pediatric hematologic disease, as well as treatment options for your child.

Tests, Treatments and Services

We offer a full range of tests, treatments, and services including:

  • checkmark icon
    Anticoagulation/Blood thinners
  • checkmark icon
    Blood product transfusions
  • checkmark icon
    Coagulation factor infusions
  • checkmark icon
    Experimental therapeutics
  • checkmark icon
    Genetic testing and counseling
  • checkmark icon
    Medication management
  • checkmark icon
    Specialized coagulation testing and counseling
  • checkmark icon
    Therapeutic apheresis

Location

2200 Children's Way, 6th Floor
Nashville, TN 37232
Today's hours:Closed